SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY.

MicroCloud Hologram Inc

MicroCloud Hologram is trending as traders discuss potential catalysts, including its crypto holdings and potential partnerships. Bullish sentiment is building with some anticipating a significant price surge, while others caution about the stock's history and financials. The community is actively debating technical indicators and potential trading strategies.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as the community rallies around its fair distribution and Bitcoin-native nature, contrasting it with other meme coins. There's excitement building around its potential, with some suggesting it could be listed on major exchanges like Coinbase. The strong community, dubbed the "Dog Army", emphasizes its decentralization and unique position within the Bitcoin ecosystem.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending due to speculation fueled by a recent disclosure of a large position taken by a U.S. Senator and Goldman Sachs increasing its stake in the company. The community is buzzing with excitement, drawing comparisons to Palantir and anticipating potential government contracts. Discussions also focus on the possibility of a short squeeze, with many expecting continued upward momentum.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as community members discuss vehicle quality concerns, service appointment availability, and the company's future prospects amid the EV landscape.  Some traders are pointing towards a potential breakout due to consolidation, while others express concerns about cash burn and production goals.  The discussion includes the upcoming R2 launch and the ongoing construction of the Georgia plant.

Shineco, Inc. is a holding company, which through its subsidiaries, engages in the production and distribution of plant-based products. It operates through the following segments: Rapid Diagnostic and Other, Other Agricultural, and Healthy Meals Products. The Rapid Diagnostic and Other Products segment is conducted through Biowin, which specializes in the development, production and distribution of innovative rapid diagnostic products and related medical devices for the most common diseases. The Other Agricultural Products segment is conducted through Wintus, which specializes in producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as trading of fresh fruit. The Healthy Meals Products segment is conducted through Fuzhou Meida, which specializes in developing healthy meals for people with slow metabolic health and those in recovery from metabolic disorders. The company was founded on August 20, 1997 and is headquartered in Beijing, China.

Shineco Inc

SISI is trending due to community speculation surrounding its low float and potential for a massive run, with some linking it to past runners like $TURB. Recent news regarding blockchain integration and cell asset tokenization is fueling excitement, though caution is advised due to the stock's history and volatility.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor Manufacturing is trending amid news of NVIDIA's CEO visiting TSM in Taipei to discuss next-generation chips and ongoing discussions with the U.S. regarding AI chip sales to China. The community is closely monitoring analyst ratings and price target adjustments, as well as the potential impact of geopolitical factors and trade dynamics on TSM's operations and valuation. Some analysts are noting the bullish outlook for TSM due to its crucial role in AI infrastructure.

The vision behind $DAIO's Reward System is simple. Those that hold and buy dips should be rewarded over jeets or buy pressure sellers. In theory if everyone held together the coin would go up right?  Sadly that is not the case but the DAIO feels those that are loyal to a coin shall be rewarded. First use case is $DAIO and the agents that follow. Phase II will unlock it's second use case, the Solana blockchain.

Decentralized AI Organization

Decentralized AI Organization ($DAIO.X) is trending as users highlight its recent launch and availability on Phantom. The community is actively encouraging others to buy in early, emphasizing its potential within the AI and crypto space. Some users are comparing it to other AI tokens and consider $DAIO.X a microcap gem with massive upside.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following news of a significant agreement with Nvidia, where Nvidia will purchase any unsold cloud capacity through 2032. Community chatter highlights the potential for a short squeeze and anticipates further positive news this week, particularly related to a potential UK deal. Some investors express caution, citing concerns about the company's debt and profitability despite the bullish news.

Turbo Energy SA provides energy solutions. It engages in the developing, manufacturing and distributing of photovoltaic products. The company was founded on September 18, 2013 and is headquartered in Valencia, Spain.

Turbo Energy S.A. - ADR

Fueled by news of a significant $53 million contract for energy storage projects in Spain, Turbo Energy (TURB) is experiencing a surge in interest and high volatility, becoming a top gainer. Community discussions revolve around the stock's potential for further gains, its low float, and comparisons to other high-flying stocks. Some traders caution against chasing the rally, citing potential pullbacks and the importance of managing risk.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending as investors discuss its potential role in securing rare earth mineral supplies, particularly with mentions of Greenland's resources and talks of a $5 billion mining fund. Community members are debating the impact of potential deals and tariff changes on the company, while highlighting the significance of rare earth elements for both defense and technology sectors. The stock's price action and future catalysts, such as funding applications and mining announcements, are also key discussion points.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Quoin Pharmaceuticals saw increased retail chatter on Wednesday after the company announced positive initial clinical data from its ongoing investigational new drug Pediatric Peeling Skin Syndrome (PSS) study evaluating QRX003.Twelve weeks of treatment produced a clear improvement in the patient's skin condition compared to initial baseline measurements.&nbsp;The stock closed at $7.65 on Wednesday, rising 20.3% during the day, but slipped 8% to $7.04 in after-hours trading.Clinical endpoints such as The Investigator's Global Assessment (IGA), Modified Ichthyosis Area Severity Index (M-IASI), and Children's Dermatology Life Quality Index (CDLQI) showed positive changes.&nbsp;The patient's IGA score changed from severe to mild, M-IASI decreased from 36 to 12, and CDLQI, the quality of life measure, fell from 19 to 11. The study reported no adverse events while administering QRX003 to patients.Quoin will extend the patient's treatment while performing additional clinical evaluations after 24 weeks of therapy.&nbsp;The firm continues to progress QRX003 through late-stage clinical trials targeting Netherton Syndrome, another uncommon skin condition.Peeling Skin Syndrome is a rare genetic disorder that manifests through excessive outer skin shedding, leading to persistent pain and itching.&nbsp;Without any existing approved treatments, the promising results from QRX003 trials suggest its potential importance if future studies confirm the positive outcomes.CEO Michael Myers stressed the clinical importance of observed improvements and pointed out QRX003's potential to become the first approved therapy for PSS, noting plans to expand the study internationally.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 2,314% surge in 24-hour message volume.One user noted that some investors with less conviction tend to sell just before market close, expressing hope that the stock would open at $20.&nbsp;<stembedurl>https://stocktwits.com/89gt/message/614698425</stembedurl>Another user highlighted the stock’s potential for rapid movement due to its very low float and recent positive news.<stembedurl>https://stocktwits.com/MasterofThePennies/message/614637863</stembedurl>The stock has declined 67.5% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Retail Buzz Intensifies Around Quoin Pharma Stock After Positive Pediatric Skin Study Data

The stock closed up 20% on Wednesday, driven by promising patient outcomes and no reported adverse events for its Pediatric Peeling Skin Syndrome (PSS) drug, with further treatment and evaluations planned.

Equity

Maxim Group Sticks to Their Buy Rating for Quoin Pharmaceuticals (QNRX)

Maxim Group analyst Naz Rahman reiterated a Buy rating on Quoin Pharmaceuticals (QNRX Research Report) yesterday. The company's shares opened tod...

Q4 2023 Quoin Pharmaceuticals Ltd Earnings Call Transcript

Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results

Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical...

Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET

ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a clinical stage specialty pharmaceutical company focused on rare and orphan...

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers

Regenxbio, Quoin Pharmaceuticals, Renalytix among healthcare movers...

Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public Offering

ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin ), a specialty pharmaceutical company focused on rare and orphan diseases, today...

Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers

Vivani Medical, Altamira Therapeutics, Quoin Pharmaceuticals among healthcare movers...

12 titoli sanitari in movimento, pre-market del 04/03/2024

Titoli in rialzo
Il titolo Quoin Pharmaceuticals (NASDAQ:QNRX) salito del 129,59% a 6,36 dollari durante la sessione pre-market di luned .
Le azioni di Renalytix (NASDAQ:RNLX) hanno guadagnato il...

12 acciones de salud en movimiento durante la preapertura del 04/03/2024

Acciones al alza
Quoin Pharmaceuticals (NASDAQ:QNRX) crecieron un 129,95% para establecerse en los 6,37 d lares durante la sesi n del pre-market del lunes.
Ainos (NASDAQ:AIMD) experimentaron un...

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

Current Price	$10.81
Prev Close	$7.82
Open	$7.81
Dividend Yield	0.00%
50-Day Moving Average	$7.76
Beta	1.40
Avg. Volume	3,237.81
PE Ratio	-0.02

52-Week High	$54.95
52-Week Low	$5.01
Market Capitalization	$4.6M
EPS (Annual)	-$67.17
Price to Book	1.80
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

QNRX
Quoin Pharmaceuticals Ltd - ADR

Feed

News

Sentiment

Fundamentals

Info

Latest QNRX News

QNRX Quoin Pharmaceuticals Ltd - ADR